Larvol Delta - A-Phase-II-Clinical-Study-Evaluating-the-Safety-TolerabilityPharmacokinetics-and-Preliminary-Efficacy-of-JS212-andJS213-as-Monotherapy-and-in-Combination-in-Patients-Withadvanced-Malignant-Solid-Tumors

AWT020 - Anwita Biosci

JS212 - Shanghai Junshi Biosci

JS207 - Shanghai Junshi Biosci

Loqtorzi (toripalimab-tpzi) - Shanghai Junshi Biosci, Coherus Oncology

http://clinicaltrials.gov/ct2/show/NCT07480733

Mar 19, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next